Well, we're all familiar with gas shortages. It appears (according to my hospital in the North of England) that there is also a global shortage of tracer dye. (Who knew?) As a result the CT scan that I was scheduled for last week has been cancelled, with no immediate prospect of tracer dye so that scans can resume. The UK has become a 3rd world-country, apparently.
Anyway, I still have a consultation with my onco booked and, with my PSA doubling on Bicalutamide and Lupron (equivalent) I'm not content in just letting things slide until I can get the scan. When we talked previously, he said that approval had been granted for both Apalutamide and Daralutamide. So, my instinct is to say 'put me on one of those'. But, which one? And, since the strategy is changing, this might be the time to suggest trying BAT. I know some have found some success with BAT, and I'm willing to give it a shot.
I'd therefore welcome any views, evidence, personal experience on both counts (which 'mide' and yes/no on BAT) I was intruiged by this paper: sciencedirect.com/science/a...
That said, I suspect that, until I've had a scan, he will be reluctant take any experiments. But he has been supportive in the past of my attempts to try non-SOC approaches.
Your thoughts as ever gratefully received.